Medical News

RSS

Idera Pharmaceuticals commences phase 1 IMO-2125 clinical trial for chronic HCV infection

Idera Pharmaceuticals, Inc. today announced that patient treatment has been initiated in a phase 1 clinical trial evaluating IMO-2125 in combination with ribavirin in treatment-naive patients with chronic hepatitis C virus (HCV) infection. IMO-2125 is a novel agonist of Toll-like Receptor (TLR) 9.

7 Oct 2009

Researchers validate a technique capable of quick TB diagnosis

The team headed by Doctor Manuel Casal, head of Microbiology at Reina Sofia Hospital in Cordoba has validated in patients a technique, originally produced by a German company, capable of diagnosing tuberculosis in only one day and determining whether or not it is resistant to two of the drugs used to treat this disease.

7 Oct 2009

Aryx Therapeutics to raise up to $35 million from sale of its common stock

ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has secured a committed equity financing facility under which it may sell up to $35 million of shares of its common stock to Commerce Court Small Cap Value Fund, Ltd. (“Commerce Court”) over a 24 month period. The maximum number of shares that can be sold by ARYx is specified in the agreement. ARYx is not obligated to utilize any of the $35 million facility and remains free to enter into and consummate other equity and debt financing transactions.

7 Oct 2009

Research study to determine association of CYP2D6 variation with tamoxifen therapy

Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.

7 Oct 2009

Tranziger forms global advisory and business team to execute strategic transactions

Tranziger Limited announced today the formation of its global advisory and business team to advise and assess companies in the life sciences and healthcare sectors to execute strategic transactions and realise and optimise value from their portfolios in these turbulent times. Tranziger Limited is headquartered in London, England, UK and has offices in Washington, DC and Edinburgh.

7 Oct 2009

Roche and Genentech obtain license to use SurModics’ drug delivery system

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has signed a License and Development Agreement with Roche and Genentech, Inc., a wholly-owned member of the Roche Group.

7 Oct 2009

CBI announces agenda for upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco

The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce the full agenda for the upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco on November 19, 2009.

7 Oct 2009

Government handout of samples of potassium iodide helps to boost sales for Nukepills.com

The recent localized government handout of samples of potassium iodide has sky-rocketed sales for online merchant Nukepills.com. Recent retail orders of Iosat(TM) Potassium Iodide have increased by almost 400% and wholesale orders to vendors and medical facilities have surged as well for the authorized national distributor.

7 Oct 2009

Researchers tune Diffuse Optical Tomography for early detection of breast cancer

Clemson University researchers in collaboration with researchers at the University of Bremen, Germany, are working to make the physical pain and discomfort of mammograms a thing of the past, while allowing for diagnostic imaging eventually to be done in a home setting.

7 Oct 2009

Uterine artery embolization proves to be better than laparoscopic occlusion of uterine arteries in treating fibroids

BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.

7 Oct 2009

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

7 Oct 2009

Minimally invasive sling operations for stress urinary incontinence found promising

New, less invasive surgical treatments for stress urinary incontinence in women are just as effective as traditional open surgical approaches, according to Cochrane Researchers. The researchers carried out a systematic review of trials comparing different surgical approaches to treating the condition.

7 Oct 2009

Arrayit Corporation CEO updates shareholders

With the start of trading of Arrayit Corporation (ARYC) on the bulletin board in March, 2009, we initiated a deliberate and measured strategy to introduce Arrayit's scientific accomplishments of the past 13 years to our shareholders. As we have laid the foundation for the announcement of future initiatives through this awareness campaign, we have seen interest in our stock steadily increase.

7 Oct 2009

India's effort to combat poverty set back by years due to floods and droughts

Massive food shortages are now impacting hundreds of millions of Indians with floods and droughts, setting back efforts to combat poverty by years, warns World Vision.

7 Oct 2009

Aspenbio Pharma declares public offering Of 4,482,609 common stock

AspenBio Pharma, Inc. today announced that it has priced a public offering of 4,482,609 shares of its common stock at $1.70 per share.

7 Oct 2009

Shire publishes efficacy study results of FOSRENOL and Renagel

Shire plc, the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate) and sevelamer hydrochloride (Genzyme's Renagel(R)) in chronic kidney disease (CKD) patients on haemodialysis.

7 Oct 2009

Stereotaxis receives commitment letter from Silicon Valley Bank

Stereotaxis, Inc. today announced that it has received a commitment letter from Silicon Valley Bank, a member company of SVB Financial Group (Nasdaq: SIVB), to increase and extend its credit facility.

7 Oct 2009

Electrostimulation techniques for osteoarthritis still unclear

Despite twenty years of research on the use of electrostimulation techniques (TENS) for treatment of osteoarthritis in the knee, researchers still cannot say whether it reduces pain or physical disability. This is the conclusion of a Cochrane Systematic Review of electrostimulation trials in osteoarthritis

7 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

2010 Medco Medicare Prescription Plan to identify lower-cost medication options

Medco Health Solutions, Inc. (NYSE: MHS) is helping seniors in this tough economy find smart solutions for getting the most value out of their Medicare prescription drug plan.

7 Oct 2009

Medical News

Idera Pharmaceuticals commences phase 1 IMO-2125 clinical trial for chronic HCV infection

Researchers validate a technique capable of quick TB diagnosis

Aryx Therapeutics to raise up to $35 million from sale of its common stock

Research study to determine association of CYP2D6 variation with tamoxifen therapy

Tranziger forms global advisory and business team to execute strategic transactions

Roche and Genentech obtain license to use SurModics’ drug delivery system

CBI announces agenda for upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco

Government handout of samples of potassium iodide helps to boost sales for Nukepills.com

Researchers tune Diffuse Optical Tomography for early detection of breast cancer

Uterine artery embolization proves to be better than laparoscopic occlusion of uterine arteries in treating fibroids

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Minimally invasive sling operations for stress urinary incontinence found promising

Arrayit Corporation CEO updates shareholders

India's effort to combat poverty set back by years due to floods and droughts

Aspenbio Pharma declares public offering Of 4,482,609 common stock

Shire publishes efficacy study results of FOSRENOL and Renagel

Stereotaxis receives commitment letter from Silicon Valley Bank

Electrostimulation techniques for osteoarthritis still unclear

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

2010 Medco Medicare Prescription Plan to identify lower-cost medication options

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News